White blood cell BRCA1 promoter methylation status and ovarian cancer risk.
dc.contributor.author | Lønning, P | |
dc.contributor.author | Berge, E | |
dc.contributor.author | Bjørnslett, M | |
dc.contributor.author | Minsaas, L | |
dc.contributor.author | Chrisanthar, R | |
dc.contributor.author | Høberg-Vetti, H | |
dc.contributor.author | Dulary, C | |
dc.contributor.author | Busato, F | |
dc.contributor.author | Bjørneklett, S | |
dc.contributor.author | Eriksen, C | |
dc.contributor.author | Kopperud, R | |
dc.contributor.author | Axcrona, U | |
dc.contributor.author | Davidson, B | |
dc.contributor.author | Bjørge, L | |
dc.contributor.author | Evans, G | |
dc.contributor.author | Howell, Anthony | |
dc.contributor.author | Salvesen, H | |
dc.contributor.author | Janszky, I | |
dc.contributor.author | Hveem, K | |
dc.contributor.author | Romundstad, P | |
dc.contributor.author | Vatten, L | |
dc.contributor.author | Tost, J | |
dc.contributor.author | Dørum, A | |
dc.contributor.author | Knappskog, S | |
dc.date.accessioned | 2018-04-29T21:02:52Z | |
dc.date.available | 2018-04-29T21:02:52Z | |
dc.date.issued | 2018-03-06 | |
dc.identifier.citation | White blood cell BRCA1 promoter methylation status and ovarian cancer risk. 2018, 168(5): 326-334 Ann Intern Med | en |
dc.identifier.issn | 1539-3704 | |
dc.identifier.pmid | 29335712 | |
dc.identifier.doi | 10.7326/M17-0101 | |
dc.identifier.uri | http://hdl.handle.net/10541/620926 | |
dc.description.abstract | The role of normal tissue gene promoter methylation in cancer risk is poorly understood. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Annals of internal medicine | en |
dc.title | White blood cell BRCA1 promoter methylation status and ovarian cancer risk. | en |
dc.type | Article | en |
dc.contributor.department | University of Bergen and Haukeland University Hospital, Bergen, Norway | en |
dc.identifier.journal | Annals of Internal Medicine | en |
html.description.abstract | The role of normal tissue gene promoter methylation in cancer risk is poorly understood. |